Home
Orbimed Advisors, Director: ArriVent BioPharma AVBP Buy · Filed 24/01/31
Trade details
- Type
- Insider buy
- Amount
- $3,999,996
- Shares · price
- 222,222 sh · $18.00 a share
- Held after
- 1,513,664 sh
- Person
- Orbimed AdvisorsDirector
- Trade date
- 24/01/30
- Filed
- 24/01/31
- Days to filing
- 1 days
First buy since 2023
- Insiders buying this week
- 8 insiders
- Holding change
- +17.2%
ArriVent BioPharma trades, last 26 weeks
What else happened in ArriVent BioPharma around then
Filed or reported within 30 days of the trade day · 23/12/31~24/02/29Orbimed Advisors's recent trades
- Orbimed Advisors
BuyADARx Pharmaceuticals
BuyADARx Pharmaceuticals
ADRX
$10M
588,235 sh
$10M
Filed 09/30
Traded 09/28
- Orbimed Advisors
BuyADARx Pharmaceuticals
BuyADARx Pharmaceuticals
ADRX
$5.1M
300,249 sh
$5.1M
Filed 09/30
Traded 09/28
- Orbimed Advisors
BuyADARx Pharmaceuticals
BuyADARx Pharmaceuticals
ADRX
$1M
61,516 sh
$1M
Filed 09/30
Traded 09/28
- Orbimed Advisors
BuyElectra Therapeutics
BuyElectra Therapeutics
ETRA
$15M
1,000,000 sh
$15M
Filed 09/23
Traded 09/21
- Orbimed Advisors
BuyElectra Therapeutics
BuyElectra Therapeutics
ETRA
$5M
333,333 sh
$5M
Filed 09/23
Traded 09/21
